NEW DELHI – India will not allow the export of the Oxford University-AstraZeneca coronavirus vaccine for several months, the head of Serum Institute of India, which has been contracted to make 1 billion doses of the vaccine for developing nations, said Sunday.With rich nations reserving most of the vaccines that will be made this year, Serum Institute — the world’s largest vaccine manufacturer — is likely to make most of the inoculations for developing countries.
The ban on exports, however, means that poorer nations will probably have to wait a few months before receiving their first shots.The vaccine was granted emergency authorization by the Indian regulator on Sunday, but on the condition that Serum Institute doesn't export the shots to.